Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$32.1K Buy
250
+200
+400% +$23.4K 0.01% 184
2026
Q1
$5.98K Buy
50
+1
+2% +$115 ﹤0.01% 263
2025
Q4
$5.19K Hold
49
– – ﹤0.01% 268
2025
Q3
$4.1K Buy
49
+1
+2% +$82 ﹤0.01% 276
2025
Q2
$3.83K Hold
48
– – ﹤0.01% 269
2025
Q1
$4.3K Sell
48
-113
-70% -$10.6K ﹤0.01% 260
2024
Q4
$16K Buy
+161
New +$16.6K 0.01% 187

Other funds holding MRK

Graney & King's MRK Position: Q2 2026 in Review

Graney & King increased its Merck (MRK) stake by 400% in Q2 2026, buying an estimated $23.4K and bringing the position to 250 shares worth $32.1K. The position accounts for 0.01% of the portfolio, ranked #184.

Graney & King first reported a position in MRK in Q4 2024 and has held it in 7 quarters since. 3,852 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Graney & King held 250 shares of Merck worth $32.1K as of Q2 2026.
  • Graney & King bought 200 Merck shares in Q2 2026, an estimated $23.4K.
  • Merck made up 0.01% of Graney & King's portfolio in Q2 2026, its #184 holding.
  • Graney & King first reported a position in Merck in Q4 2024 and has held it in 7 quarters since.
  • 3,852 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Graney & King's 13F filing for Q2 2026, filed 7 Aug 2026.